[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367694-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367694-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","development-and-validation-of-machine-learning-models-for-early-diagnosis-and-prognosis-of-lung-adenocarcinoma-using-mirna-expression-profiles","Development and validation of machine learning models for early diagnosis and prognosis of lung adenocarcinoma using miRNA expression profiles","","Objective: develop diagnostic and prognostic machine learning models for lung adenocarcinoma (LUAD) to improve clinical decision accuracy. Methods: TCGA-derived LUAD data were split into training (n=196) and test sets (n=133); miRNA feature selection used LASSO, Random Forest, and SVM. Six algorithms predicted pulmonary node classification, and performance was assessed with ROC, PR, and error rates; prognosis used Lasso Cox regression with risk scores, Kaplan–Meier, and time-dependent ROC. Functional enrichment explored miRNA mechanisms. Results identify five diagnostic miRNAs and a 13-miRNA prognostic model associated with outcomes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/development-and-validation-of-machine-learning-models-for-early-diagnosis-and-prognosis-of-lung-adenocarcinoma-using-mirna-expression-profiles/367694/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/development-and-validation-of-machine-learning-models-for-early-diagnosis-and-prognosis-of-lung-adenocarcinoma-using-mirna-expression-profiles/367694.png","ImageObject",300,407,{"name":42,"@type":43},"Stanford","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main objective of the study for LUAD?","Question",{"text":63,"@type":64},"To develop machine learning-based diagnostic and prognostic models for lung adenocarcinoma using miRNA expression profiles to enhance clinical decision-making accuracy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the models trained and validated?",{"text":68,"@type":64},"TCGA LUAD data were split into training (n=196) and test sets (n=133), with miRNA feature selection using LASSO, Random Forest, and SVM and model evaluation using ROC, PR, error rates, and time-dependent ROC.",{"name":70,"@type":61,"acceptedAnswer":71},"Which miRNAs were identified for diagnosis and prognosis?",{"text":72,"@type":64},"Feature selection identified five miRNAs distinguishing early-stage LUAD from adjacent non-cancerous tissues, and a prognostic model based on 13 miRNAs predicted poorer outcomes for higher-risk patients.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367694,1790966349,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},2336477552062,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Development and validation of machine learning models for early diagnosis and prognosis of lung adenocarcinoma using miRNA expression proﬁles  \nLin Lin 1 and Yongxia Bao 1  \nCancer Biomarkers Vol. 42(1): 1–16 © The Author(s) 2025 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/18758592241308756](DOI: 10.1177/18758592241308756)[ ](DOI: 10.1177/18758592241308756)[journals.sagepub.com/home/cbm](journals.sagepub.com/home/cbm)  \nAbstract  \nObjective: Study aims to develop diagnostic and prognostic models for lung adenocarcinoma (LUAD) using Machine learning（ML）algorithms, aiming to enhance clinical decision-making accuracy.  \nMethods: Data from The Cancer Genome Atlas (TCGA) for LUAD patients were split into training (n = 196) and test sets (n = 133). Feature selection (Least Absolute Shrinkage and Selection Operator (LASSO), Random Forest (RF), and Support Vector Machine (SVM)) identiﬁed miRNAs distinguishing stage I LUAD. Six ML algorithms predicted pulmonary node classiﬁcation. Model performance was evaluated using Receiver Operating Characteristic (ROC) curve, PrecisionRecall (PR) curves, and Error Rates (CE). A prognostic model was constructed using Lasso Cox regression. Risk score plots were generated, and model performance was assessed using Kaplan-Meier (K-M) and time-dependent ROC curves. Functional enrichment analyses investigated miRNA function and mechanism.  \nResults: The feature selection results identiﬁed ﬁve miRNA molecules as distinguishing characteristics between earlystage LUAD and adjacent non-cancerous tissues. A prognostic model using 13 miRNAs predicted poorer outcomes for patients with higher risk scores, supported by time-dependent ROC curves and a nomogram. Functional enrichment analysis identiﬁed cancer-related signaling pathways for the biomarkers.  \nConclusion: ML identiﬁed a diagnostic ﬁve-miRNA signature and a prognostic 13-miRNA model for LUAD, both robust and reliable.  \nKeywords  \nlung adenocarcinoma, machine learning, miRNA, prognostic model  \nReceived: 6 March 2024; accepted: 25 November 2024  \nIntroduction  \nLung cancer is still the main cause of cancer-associated death worldwide.1 Lung adenocarcinoma (LUAD) is the most common type, accounting for about 40% of all lung cancers.2 With the wide application of low-dose spiral computed tomography (LDCT), the detection rate of pulmonary nodules is increasing year by year. However, low-dose CT screening for lung cancer often fails to distinguish between benign and malignant early lung nodules.3 Timely determination of which lung nodules are early lung adenocarcinoma is crucial for early detection and treatment of lung adenocarcinoma. In addition, several factors are routinely used as prognostic indicators for predictive prognosis of LUAD, including tumor size, nodal status, distant metastasis and  \ntumor mutational burden.4 However, malignant tumors are highly heterogeneous at multiple levels and even patients with the same tumor stage still have a great difference in prognosis and response to therapy.5,6 Sometimes, they do  \n1 Department of Respiratory and Critical Care Medicine, The Second Afﬁliated Hospital of Harbin Medical University, Harbin, Heilongjiang, People’s Republic of China  \nCorresponding author:  \nYongxia Bao, Department of Respiratory and Critical Care Medicine, The Second Afﬁliated Hospital of Harbin Medical University, No.246 Xue Fu Road, Nangang District, Harbin, Heilongjiang, 150000, People’s Republic of China.  \nEmail: [hydbaoyongxia@163.com](hydbaoyongxia@163.com)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution  \nNonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction and distribution of the work without further permission provided the origi","cbCaimnnCXq9zvJM","https://ap.wps.com/l/cbCaimnnCXq9zvJM","pdf",3019154,16,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the main objective of the study for LUAD?\",\"answer\":\"To develop machine learning-based diagnostic and prognostic models for lung adenocarcinoma using miRNA expression profiles to enhance clinical decision-making accuracy.\"},{\"question\":\"How were the models trained and validated?\",\"answer\":\"TCGA LUAD data were split into training (n=196) and test sets (n=133), with miRNA feature selection using LASSO, Random Forest, and SVM and model evaluation using ROC, PR, error rates, and time-dependent ROC.\"},{\"question\":\"Which miRNAs were identified for diagnosis and prognosis?\",\"answer\":\"Feature selection identified five miRNAs distinguishing early-stage LUAD from adjacent non-cancerous tissues, and a prognostic model based on 13 miRNAs predicted poorer outcomes for higher-risk patients.\"}]","Development and validation of machine learning models for early diagnosis and prognosis of lung adenocarcinoma using miRNA expression profiles | PDF",1790172079,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/49cf3969ba56fc0ce63d2f4482b0b9f1.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9570371d41a81a4fa74f59bec766fe3.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f13ed88f184a8235e405bbf445727c2.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a126798001fc4df2705c315eaeb61a3.webp",980,1306]